Oleoyl-Estrone

Oleoyl-estrone (OE) is a powerful slimming agent that is also present in plasma and adipose tissue, where it is synthesized. It acts through the formation of a derivative W. OE effects (and W levels) are proportional to the dose. OE reduces food intake but maintains energy expenditure (thermogenesis...

ver descrição completa

Detalhes bibliográficos
Autores: Remesar Betlloch, Xavier, Fernández López, José Antonio, Alemany, Marià, 1946-
Formato: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2012
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/130029
Acesso em linha:https://hdl.handle.net/2445/130029
Access Level:acceso abierto
Palavra-chave:Teixit adipós
Oleat d'estrona
Adipose tissues
Oleoyl-estrone
id ES_092c85028c6b7595fbfa32c1f3efa8fc
oai_identifier_str oai:recercat.cat:2445/130029
network_acronym_str ES
network_name_str España
repository_id_str
spelling Oleoyl-EstroneRemesar Betlloch, XavierFernández López, José AntonioAlemany, Marià, 1946-Teixit adipósOleat d'estronaAdipose tissuesOleoyl-estroneOleoyl-estrone (OE) is a powerful slimming agent that is also present in plasma and adipose tissue, where it is synthesized. It acts through the formation of a derivative W. OE effects (and W levels) are proportional to the dose. OE reduces food intake but maintains energy expenditure (thermogenesis). The energy gap is fulfilled with adipose tissue fat, sparing body protein and maintaining glycemia (and glycogen) with lower insulin and leptin levels. OE (in fact W) acts through specific receptors, different from those of estrogen. OE increases cholesterol catabolism, reducing hypercholesterolemia in obese rats. The main metabolic effect on adipose tissue is a lowering of lipid synthesis, maintaining unchanged the intracellular lipolytic processes; the imbalance favors the progressive loss of fat, which is largely used by the muscle. OE administration induces additive effects with other antiobesity agents, such as β3-adrenergic agonists, forcing a massive loss of lipid. Corticosteroids, markedly limit OE action by altering the liver control of lipogenesis. OE also inhibits the action of 17β-hydroxysteroid dehydrogenase, decreasing the synthesis of β-estradiol and testosterone. Discontinuous treatment allows for maximal efficacy both in rats and humans. OE has the advantage that the loss of fat is maintained and does not require additional dietary limitations.Wiley2019201920122019info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersion29 p.application/pdfhttps://hdl.handle.net/2445/130029Articles publicats en revistes (Bioquímica i Biomedicina Molecular)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésVersió postprint del document publicat a: https://doi.org/10.1002/med.20240Medicinal Research Reviews, 2012, vol. 32, num. 6, p. 1263-1291https://doi.org/10.1002/med.20240(c) Wiley, 2012info:eu-repo/semantics/openAccessoai:recercat.cat:2445/1300292026-05-29T05:05:01Z
dc.title.none.fl_str_mv Oleoyl-Estrone
title Oleoyl-Estrone
spellingShingle Oleoyl-Estrone
Remesar Betlloch, Xavier
Teixit adipós
Oleat d'estrona
Adipose tissues
Oleoyl-estrone
title_short Oleoyl-Estrone
title_full Oleoyl-Estrone
title_fullStr Oleoyl-Estrone
title_full_unstemmed Oleoyl-Estrone
title_sort Oleoyl-Estrone
dc.creator.none.fl_str_mv Remesar Betlloch, Xavier
Fernández López, José Antonio
Alemany, Marià, 1946-
author Remesar Betlloch, Xavier
author_facet Remesar Betlloch, Xavier
Fernández López, José Antonio
Alemany, Marià, 1946-
author_role author
author2 Fernández López, José Antonio
Alemany, Marià, 1946-
author2_role author
author
dc.subject.none.fl_str_mv Teixit adipós
Oleat d'estrona
Adipose tissues
Oleoyl-estrone
topic Teixit adipós
Oleat d'estrona
Adipose tissues
Oleoyl-estrone
description Oleoyl-estrone (OE) is a powerful slimming agent that is also present in plasma and adipose tissue, where it is synthesized. It acts through the formation of a derivative W. OE effects (and W levels) are proportional to the dose. OE reduces food intake but maintains energy expenditure (thermogenesis). The energy gap is fulfilled with adipose tissue fat, sparing body protein and maintaining glycemia (and glycogen) with lower insulin and leptin levels. OE (in fact W) acts through specific receptors, different from those of estrogen. OE increases cholesterol catabolism, reducing hypercholesterolemia in obese rats. The main metabolic effect on adipose tissue is a lowering of lipid synthesis, maintaining unchanged the intracellular lipolytic processes; the imbalance favors the progressive loss of fat, which is largely used by the muscle. OE administration induces additive effects with other antiobesity agents, such as β3-adrenergic agonists, forcing a massive loss of lipid. Corticosteroids, markedly limit OE action by altering the liver control of lipogenesis. OE also inhibits the action of 17β-hydroxysteroid dehydrogenase, decreasing the synthesis of β-estradiol and testosterone. Discontinuous treatment allows for maximal efficacy both in rats and humans. OE has the advantage that the loss of fat is maintained and does not require additional dietary limitations.
publishDate 2012
dc.date.none.fl_str_mv 2012
2019
2019
2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/130029
url https://hdl.handle.net/2445/130029
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Versió postprint del document publicat a: https://doi.org/10.1002/med.20240
Medicinal Research Reviews, 2012, vol. 32, num. 6, p. 1263-1291
https://doi.org/10.1002/med.20240
dc.rights.none.fl_str_mv (c) Wiley, 2012
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) Wiley, 2012
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 29 p.
application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv Articles publicats en revistes (Bioquímica i Biomedicina Molecular)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869403090522734592
score 15,812455

Registos relacionados